Skip to content
  • facebook.com
  • twitter.com
  • t.me
  • instagram.com
  • youtube.com
BioTechGrid

BioTechGrid

  • Home
  • Biotechnology
  • Medical Technology
  • Research
  • Genetics
  • Press Releases
    • Business Wire
    • GlobeNewswire
    • PRNewswire
  • Contact
Posted inBiotechnology

ACS Unifies Its Identity to Advance Science and Support Its People

August 5, 2026
Continue Reading
acs-unifies-its-identity-to-advance-science-and-support-its-people
Posted inBiotechnology

Study Finds Newborn Circumcision Does Not Increase Autism Risk

August 5, 2026
Continue Reading
study-finds-newborn-circumcision-does-not-increase-autism-risk
Posted inBiotechnology

Yao Earns Prestigious NSF CAREER Award

August 5, 2026
Continue Reading
yao-earns-prestigious-nsf-career-award
Posted inBiotechnology

New strategy shows promise against cancer drug resistance

August 4, 2026
Continue Reading
new-strategy-shows-promise-against-cancer-drug-resistance
Posted inBiotechnology

China study finds hospitals minimally affect antibiotic resistance in nearby waters

August 4, 2026
Continue Reading
china-study-finds-hospitals-minimally-affect-antibiotic-resistance-in-nearby-waters
Posted inBiotechnology

GLP-1 drugs tied to fewer fractures in adults with type 2 diabetes

August 4, 2026
Continue Reading
glp-1-drugs-tied-to-fewer-fractures-in-adults-with-type-2-diabetes
Most Popular Post
exploring-the-future-of-healthcare with-panos-karelis
Posted inArtificial intelligence

Exploring the Future of Healthcare with Panos Karelis

exploring-the-future-of-healthcare with-gordon-wishart,-check4cancer
Posted inArtificial intelligence

Exploring the Future of Healthcare with Gordon Wishart, Check4Cancer

exploring-the-future-of-healthcare with-noam-shomron,-tel-aviv-university
Posted inArtificial intelligence

Exploring the Future of Healthcare with Noam Shomron, Tel Aviv University

exploring-the-future-of-healthcare with-raul-villamarin-rodriguez,-woxsen-university
Posted inArtificial intelligence

Exploring the Future of Healthcare with Raul Villamarin Rodriguez, Woxsen University

fierce-biotech-layoff-tracker-2025:-cytomx-cuts-team-by-40%
Posted inBiotechnology

Fierce Biotech Layoff Tracker 2025: CytomX cuts team by 40%

December 23, 2024
We hoped industry layoffs would relent in 2024. That's not what happened. Overall, biopharma layoffs rose 3% last year compared…
Read More
editor’s-corner:-fierce-medtech’s-top-10-stories-of-2024-chart-the-industry’s-highs-and-lows
Posted inMedical Technology

Editor’s corner: Fierce Medtech’s top 10 stories of 2024 chart the industry’s highs and lows

December 23, 2024
A look back at our top stories of 2024 sees them fall into two major themes: promise, and a realignment…
Read More
fda-approves-humacyte’s-off-the-shelf-artery-implant-for-vascular-trauma-repair
Posted inMedical Technology

FDA approves Humacyte’s off-the-shelf artery implant for vascular trauma repair

December 23, 2024
The FDA has granted a groundbreaking approval to Humacyte for its off-the-shelf, bioengineered blood vessel implant, designed to replace a…
Read More
ikena,-after-tough-year-of-layoffs,-merges-with-inmagene-to-focus-on-phase-2-dermatitis-prospect
Posted inBiotechnology

Ikena, after tough year of layoffs, merges with Inmagene to focus on phase 2 dermatitis prospect

December 23, 2024
After a year that saw Ikena Oncology trim back its workforce and pipeline, the oncology biotech thinks it has found…
Read More
rapt-re-rolls-after-flameout,-paying-$35m-for-challenger-to-novartis,-roche-drug
Posted inBiotechnology

Rapt re-rolls after flameout, paying $35M for challenger to Novartis, Roche drug

December 23, 2024
Rapt Therapeutics has charted a new course following the implosion of its lead program, agreeing to pay $35 million for a…
Read More
sanofi-pays-sk-bioscience-e50m-as-children’s-pneumococcal-vaccine-enters-phase-3
Posted inBiotechnology

Sanofi pays SK bioscience €50M as children’s pneumococcal vaccine enters phase 3

December 23, 2024
Sanofi is handing SK bioscience 50 million euros ($52 million) as the longtime partners take their next-gen pneumococcal conjugate vaccine…
Read More
phase-2-data-will-drive-biopharma-vc-investments-next-year:-pitchbook
Posted inBiotechnology

Phase 2 data will drive biopharma VC investments next year: PitchBook

December 23, 2024
Phase 2 trial data will continue to be the name of the game when it comes to VC investments into…
Read More
stockwatch:-wall-street’s-leaders-and-laggards-of-2024
Posted inGenetics

StockWatch: Wall Street’s Leaders and Laggards of 2024

December 21, 2024
2024 had its dazzling moments, but, in the end, it was a year of treading water for biopharma stocks, judging…
Read More
Posted inBiotechnology

Discover Astellas’ differentiated approach to innovation partnerships

December 20, 2024
As a global life sciences company, Astellas is passionate about partnering to advance life-changing treatments for patients. If you are…
Read More
clinical-trials-industry-to-grapple-with-new-tech,-additional-uncertainty-in-2025:-velocity-clinical-research-ceo
Posted inResearch

Clinical trials industry to grapple with new tech, additional uncertainty in 2025: Velocity Clinical Research CEO

December 20, 2024
Clinical trials in 2025 will be beset by rising costs and uncertain regulations while also benefiting from new technologies and…
Read More

Posts pagination

Previous page 1 … 2,124 2,125 2,126 2,127 2,128 … 2,141 Next page
You May Have Missed
Posted inMedical Technology

Smith & Nephew cuts 2026 outlook as US knee implant sales slide

Posted inMedical Technology

KKR inks $5.7B deal to take medtech manufacturing giant Integer private

Posted inMedical Technology

Curium strikes up to $8B deal for radiopharma rival Lantheus

Posted inMedical Technology

Labcorp posts higher Q2 earnings on strength of diagnostics, lab services; adjusts full-year guidance

Privacy Policy    Terms

Scroll to Top